Viewing nowCombinationAmozyltan XQ Tablet 5/100/10/10 mg
Losartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202007696 · Approved 2020.11.09 · Insurance code 643508330
Treatment of dyslipidemia (hypercholesterolemia, etc.) and hypertension
This medication is used for patients who have both hypertension and dyslipidemia. First, the amlodipine/losartan combination is effective for patients with essential hypertension whose blood pressure is difficult to control, particularly suitable for initial treatment of stage 2 hypertension. Moreover, the rosuvastatin/ezetimibe combination helps to control cholesterol and triglyceride levels in patients with primary hypercholesterolemia or mixed dyslipidemia. This medication is used in conjunction with dietary therapy, and it is important to identify and treat other secondary causes. Thus, it is used to effectively control blood pressure and lipid levels to reduce the risk of cardiovascular disease.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow the tablet whole without chewing, dividing, or crushing it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the anticipated likelihood of achieving the treatment goal with the combination compared with a single agent. The usual dose is amlodipine/losartan 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: Dose adjustment is not required in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: In older adults aged 75 years or over, an initial losartan dose of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended initial dose is 5/10 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10 mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus when administered to pregnant women, so it should be discontinued immediately if pregnancy is confirmed. When administered for the first time to patients with significantly low blood pressure or insufficient blood volume, hypotensive symptoms may occur, requiring caution. If symptoms of muscle pain or weakness occur, you should inform your physician immediately, as it can progress to severe muscle tissue destruction (rhabdomyolysis) in serious cases. Patients with an allergy to any of the components of this medication or those with certain liver or kidney diseases should not use it. Elderly patients, individuals with impaired kidney function, and those with hyperkalemia should be particularly cautious when using this medication and should regularly check their condition through blood tests or other evaluations. This medication can affect liver function, so anyone with a history of liver disease or symptoms of liver dysfunction should consult a healthcare provider immediately. Patients at higher risk of muscle-related side effects should have muscle enzyme levels tested prior to administration and should receive immediate evaluation if any muscle symptoms occur during treatment. Interactions with other medications may occur, so anyone taking other drugs should inform their healthcare provider and be cautious, especially when using this medication with antihypertensives, lipid-lowering agents, or certain antibiotics. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. If any abnormal symptoms or discomfort arise during treatment, consult a physician or pharmacist immediately.
Craniosynostosis, anuria, hypotension, renal failure, ALT elevation, AST elevation, dermatitis, orthostatic dizziness, atrial fibrillation, rhabdomyolysis, pancreatic adenocarcinoma, facial edema, unusual sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, dizziness, drowsiness, neurodegenerative disorders, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue inflammation, hepatic steatosis, liver impairment, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, cold sweats, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, ALT increase, myalgia, headache, CK increase, dizziness, constipation, asthenia, arthralgia, fatigue, numbness, paresthesia, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal bloating, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, flushing, fatigue, edema, palpitations, dizziness, headache, drowsiness, abdominal pain, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, hypertonia, sensory reduction, paresthesia, peripheral neuropathy, syncope, taste disturbance, tremors, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, dyspepsia, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, increased sweating, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary dysfunction, nocturnal enuresis, hepatitis, jaundice, elevated liver enzymes, angioedema, vasculitis, anaphylactic-like syndrome, hepatic dysfunction, intestinal vascular edema, fatigue, anemia, thrombocytopenia, myalgia, weakness, elevated creatine kinase, increased serum myoglobin, rhabdomyolysis, taste disturbance, dry cough, erythema multiforme, hyperkalemia, hyponatremia, ALT elevation, AST elevation, increased BUN, increased serum creatinine, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, renal failure, ventricular ectopy, atrial fibrillation, hypoglycemia, weakness, hunger, cold sweats, hand tremors, decreased concentration, convulsions, altered consciousness, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, urticaria, rash, dermatitis, dry skin, petechiae, erythema, photo sensitivity reaction, sweating, urticaria, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, anaphylaxis, urticaria, rash, angioedema, polycythemia, arthralgia, myalgia, increased creatine phosphokinase, myopathy, rhabdomyolysis, hepatitis, abdominal pain, thrombocytopenia, nausea, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, fatigue, chest pain, chest discomfort, edema, asthenia, generalized edema, headache, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, dry mouth syndrome, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, arthralgia, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory infection, conjunctival hyperemia, renal failure, abnormal liver function, increased serum creatinine, hypertension, increased serum urea, increased serum creatine phosphokinase, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture from entering. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This helps maintain the medication's efficacy and prevents degradation.
Red-pink oval film-coated tablet
30 tablets/box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.